Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Cellectis′ R&D Day Highlights Lasme-cel′s Potential to Address Significant Unmet Need for... (GlobeNewswire EN) +++ CELLECTIS Aktie +4,58%

ARES CAPITAL Aktie

 >ARES CAPITAL Aktienkurs 
16.75 EUR    -2.8%    (Tradegate)
Ask: 16.744 EUR / 3000 Stück
Bid: 16.704 EUR / 1800 Stück
Tagesumsatz: 10443 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ARES CAPITAL Aktie über LYNX handeln
>ARES CAPITAL Performance
1 Woche: +1,6%
1 Monat: -4,4%
3 Monate: -12,5%
6 Monate: -3,6%
1 Jahr: -12,4%
laufendes Jahr: -18,0%
>ARES CAPITAL Aktie
Name:  ARES CAPITAL CORP.
Land:  USA
Sektor:  Finanzen
ISIN/ Wkn:  US04010L1035 / A0DQY4
Symbol/ Ticker:  9A2 (Frankfurt) / ARCC (NASDAQ)
Kürzel:  FRA:9A2, ETR:9A2, 9A2:GR, NASDAQ:ARCC
Index:  -
Webseite:  https://www.arescapitalco..
Profil:  Ares Capital Corporation is a leading specialty fi..
>Volltext..
Marktkapitalisierung:  12118.16 Mio. EUR
Unternehmenswert:  23504.09 Mio. EUR
Umsatz:  2550.85 Mio. EUR
EBITDA:  1847.38 Mio. EUR
Nettogewinn:  1159.32 Mio. EUR
Gewinn je Aktie:  1.75 EUR
Schulden:  12089.35 Mio. EUR
Liquide Mittel:  568.95 Mio. EUR
Operativer Cashflow:  1093.35 Mio. EUR
Bargeldquote:  0.78
Umsatzwachstum:  -2.07%
Gewinnwachstum:  -26.94%
Dividende je Aktie:  1.71 EUR
Dividendenrendite:  9.58%
Dividendenschätzung:  9.58%
Div. Historie:  15.09.25 - 0.406992€
13.06.25 - 0.415392€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  ARES CAPITAL
Letzte Datenerhebung:  16.10.25
>ARES CAPITAL Kennzahlen
Aktien/ Unternehmen:
Aktien: 705.37 Mio. St.
Frei handelbar: 99.36%
Rückkaufquote: -10.83%
Mitarbeiter: 3200
Umsatz/Mitarb.: 0.78 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 16.52%
Bewertung:
KGV: 9.86
KGV lG: 9.91
KUV: 4.57
KBV: 1.01
PEG-Ratio: -
EV/EBITDA: 12.72
Rentabilität:
Bruttomarge: 74.64%
Gewinnmarge: 45.45%
Operative Marge: 72.42%
Managementeffizenz:
Gesamtkaprendite: 4.91%
Eigenkaprendite: 10.25%
>ARES CAPITAL Peer Group

Es sind 661 Aktien bekannt.
 
14.10.25 - 16:45
Ares Capital Corporation (ARCC) is Attracting Investor Attention: Here is What You Should Know (Zacks)
 
Zacks.com users have recently been watching Ares Capital (ARCC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects....
13.10.25 - 22:33
Ares Capital reverses course as shares shoot up after six straight sessions of declines (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.10.25 - 16:45
Is Ares Capital (ARCC) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
 
Based on the average brokerage recommendation (ABR), Ares Capital (ARCC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?...
12.10.25 - 00:24
Where Will Ares Capital Be in 5 Years? (Fool)
 
Making predictions on Wall Street is usually a mistake, but I'm confident about one call when it comes to high-yield Ares Capital....
08.10.25 - 01:45
Ares Capital (ARCC) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
 
In the latest trading session, Ares Capital (ARCC) closed at $19.86, marking a -1.29% move from the previous day....
03.10.25 - 16:45
Ares Capital Corporation (ARCC) is Attracting Investor Attention: Here is What You Should Know (Zacks)
 
Ares Capital (ARCC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock....
02.10.25 - 13:06
Ares Capital Corporation Schedules Earnings Release for the Third Quarter Ended September 30, 2025 (Accesswire)
 
NEW YORK, NY / ACCESS Newswire / October 2, 2025 / Ares Capital Corporation ("Ares Capital") (NASDAQ:ARCC) announced today that it will report earnings for the third quarter ended September 30, 202......
02.10.25 - 11:12
Why I Just Bought More of This 9.4%-Yielding Dividend Stock (Fool)
 
Ares Capital checks off the boxes for the kind of stock to buy in today's uncertain market....
02.10.25 - 01:45
Ares Capital (ARCC) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
 
In the most recent trading session, Ares Capital (ARCC) closed at $20.13, indicating a -1.37% shift from the previous trading day....
26.09.25 - 16:45
Brokers Suggest Investing in Ares Capital (ARCC): Read This Before Placing a Bet (Zacks)
 
The average brokerage recommendation (ABR) for Ares Capital (ARCC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?...
25.09.25 - 22:30
Month-End Portfolio Data Now Available for Ares Dynamic Credit Allocation Fund, Inc. (Accesswire)
 
NEW YORK, NY / ACCESS Newswire / September 25, 2025 / Ares Capital Management II LLC today announced that monthly fund composition and performance data for Ares Dynamic Credit Allocation Fund, Inc.......
25.09.25 - 15:06
Centurion One Capital Corp.: Ares Capital Markets Group is a GOLD SPONSOR at the Centurion One Capital 3rd Annual Bahamas Summit (Newsfile)
 
Miami, Florida--(Newsfile Corp. - September 25, 2025) - Ares Capital Markets Group is pleased to announce it is a GOLD Sponsor at the Centurion One Capital 3rd Annual Bahamas Summit, a two-day inv......
24.09.25 - 16:45
ARCC vs. HTGC: Which BDC Has More Upside as Rates Come Down? (Zacks)
 
Does Hercules Capital's tech and life sciences focus, rising commitments and stronger earnings outlook give it an edge over Ares Capital? Let's decode....
22.09.25 - 16:45
Ares Capital Corporation (ARCC) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
 
Zacks.com users have recently been watching Ares Capital (ARCC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects....
10.09.25 - 16:45
Wall Street Bulls Look Optimistic About Ares Capital (ARCC): Should You Buy? (Zacks)
 
The average brokerage recommendation (ABR) for Ares Capital (ARCC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?...
10.09.25 - 02:36
Is Ares Capital Stock a Buy Now? (Fool)
 
Ares Capital is a business development company (BDC) with a huge yield. If you appreciate reliable dividends it may not be the best fit for you....
10.09.25 - 01:45
Ares Capital (ARCC) Stock Sinks As Market Gains: Here′s Why (Zacks)
 
In the most recent trading session, Ares Capital (ARCC) closed at $22.24, indicating a -1.11% shift from the previous trading day....
09.09.25 - 16:45
Investors Heavily Search Ares Capital Corporation (ARCC): Here is What You Need to Know (Zacks)
 
Zacks.com users have recently been watching Ares Capital (ARCC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects....
02.09.25 - 23:33
Ares Capital prices public offering of $650 million notes due 2031 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.09.25 - 23:21
Ares Capital Corporation Prices Public Offering of $650 Million 5.100% Unsecured Notes Due 2031 (Business Wire)
 
NEW YORK--(BUSINESS WIRE)--Ares Capital Corporation (Nasdaq: ARCC) announced that it has priced an underwritten public offering of $650 million in aggregate principal amount of 5.100% notes due 2031. The notes will mature on January 15, 2031 and may be redeemed in whole or in part at Ares Capital's option at any time at par plus a “make-whole” premium, if applicable. BofA Securities, Inc., J.P. Morgan Securities LLC, RBC Capital Markets, LLC, SMBC Nikko Securities America, Inc., Wells Fargo Securities, LLC, Barclays Capital Inc., BNP Paribas Securities Corp., CIBC World Markets Corp., Mizuho Securities USA LLC, MUFG Securities Americas Inc. and Truist Securities, Inc. are acting as joint book-running managers for this offering. HSBC Securities (USA) Inc., Morgan Stanley & Co. LLC, Regions Securities LLC, SG Americas Securities, LLC, U.S. Bancorp Investments, Inc., BNY Mellon Capital Markets, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, ICBC Standa...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Egoist ist ein unfeiner Mensch, der für sich selbst mehr Interesse hat als für mich. - Ambrose Bierce
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!